Moderna to request emergency authorization of

Moderna to request emergency authorization of coronavirus vaccine. Moderna is asking the Food and Drug Administration for emergency approval of its coronavirus vaccine, the Cambridge, Mass.-based biotech firm announced Monday. Massachusetts-based biotech company Moderna said it will request an Emergency Use Authorization from the Food and Drug Administration for its coronavirus vaccine on Monday as well as conditional approval from the European Medicines Agency. Moderna CEO Stephane Bancel told "Mornings with Maria" on Monday that the FDA is expected to consider the vaccine at a Dec. 17 meeting, and that he hopes for approval in the next several weeks. "Our goal is to start vaccinating Americans within 24 hours after the FDA gives approval," Bancel said. "There were 30 severe cases in the study. All 30 were on placebo." Check out the link to read more about this.